RedHill Biopharma (Israel) Backtesting

RDHL -- Israel Stock  

ILS 252.70  1.10  0.44%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of RedHill Biopharma Ltd and determine expected loss or profit from investing in RedHill Biopharma over given investment horizon. Additionally take a look at RedHill Biopharma Hype Analysis, RedHill Biopharma Correlation, RedHill Biopharma Valuation, RedHill Biopharma Volatility as well as analyze RedHill Biopharma Alpha and Beta and RedHill Biopharma Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

RedHill Biopharma 'What if' Analysis

October 19, 2018
0.00
No Change 0.00  0.0%
In 2 months and 1 day
December 18, 2018
0.00
If you would invest  0.00  in RedHill Biopharma on October 19, 2018 and sell it all today you would earn a total of 0.00 from holding RedHill Biopharma Ltd or generate 0.0% return on investment in RedHill Biopharma over 60 days. RedHill Biopharma is related to or competes with Kamada Ltd, Compugen Ltd, Evogene Ltd, Kadimastem Ltd, and D N. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late ...

RedHill Biopharma Upside/Downside Indicators

Information Ratio(0.007737)
Maximum Drawdown22.64
Value At Risk(6.55)
Potential Upside6.86
  

RedHill Biopharma Market Premium Indicators

Risk Adjusted Performance(0.05)
Jensen Alpha(0.36)
Total Risk Alpha0.3146
Treynor Ratio0.1997

RedHill Biopharma Backtested Returns

Macroaxis considers RedHill Biopharma to be not too risky. RedHill Biopharma maintains Sharpe Ratio (i.e. Efficiency) of -0.1272 which implies RedHill Biopharma had -0.1272% of return per unit of risk over the last 2 months. Macroaxis philosophy towards forecasting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. RedHill Biopharma exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to check RedHill Biopharma Coefficient Of Variation of (2,219) and Risk Adjusted Performance of (0.05) to confirm risk estimate we provide. Macroaxis gives RedHill Biopharma performance score of 0 on a scale of 0 to 100. The organization holds Beta of -0.9789 which implies . Even though it is essential to pay attention to RedHill Biopharma current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Macroaxis philosophy towards forecasting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. RedHill Biopharma exposes twenty-one different technical indicators which can help you to evaluate its performance. RedHill Biopharma has expected return of -0.4316%. Please be advised to check RedHill Biopharma Downside Deviation, Standard Deviation, Information Ratio, as well as the relationship between Coefficient Of Variation and Variance to decide if RedHill Biopharma past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.54) 
correlation synergy

Good reverse predictability

RedHill Biopharma Ltd has good reverse predictability. Overlapping area represents the amount of predictability between RedHill Biopharma time series from October 19, 2018 to November 18, 2018 and November 18, 2018 to December 18, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RedHill Biopharma price movement. The serial correlation of -0.54 indicates that about 54.0% of current RedHill Biopharma price fluctuation can be explain by its past prices. Given that RedHill Biopharma Ltd has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of RedHill Biopharma for similar time interval.
Correlation Coefficient-0.54
Spearman Rank Test-0.09
Residual Average0.0
Price Variance309.18

RedHill Biopharma lagged returns against current returns

 Current and Lagged Values 
      Timeline 

RedHill Biopharma regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

RedHill Biopharma Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - RDHL

RedHill Biopharma Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in RedHill Biopharma Ltd. What is your perspective on investing in RedHill Biopharma Ltd? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
ANZ   
Purchased over 90 shares of
3 hours ago
Traded for 24.8
E   
Purchased over 90 shares of
few hours ago
Traded for 31.58
T   
Purchased over 90 shares of
few hours ago
Traded for 29.8
C   
Purchased over 50 shares of
few hours ago
Traded for 54.4
GOOG   
Purchased few shares of
few hours ago
Traded for 1016.53
Additionally take a look at RedHill Biopharma Hype Analysis, RedHill Biopharma Correlation, RedHill Biopharma Valuation, RedHill Biopharma Volatility as well as analyze RedHill Biopharma Alpha and Beta and RedHill Biopharma Performance. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Search macroaxis.com